<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Converging evidence suggests that inflammatory processes significantly influence brain injury and clinical impairment in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although early studies suggested a key role of lymphocytes, recent data has emphasized the orchestrating function of innate immunity, i.e., macrophages and microglia </plain></SENT>
<SENT sid="2" pm="."><plain>The bifunctional receptor and ectoenzyme CD38 synthesizes calcium-mobilizing second messengers (e.g., cyclic <z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>), which have been shown to be necessary for activation and migration of myeloid immune cells </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, we investigated the dynamics of CD38 in <z:hpo ids='HP_0001297'>stroke</z:hpo> and the impact of CD38-deficiency on cytokine production, <z:mp ids='MP_0001845'>inflammation</z:mp> and cerebral damage in a mouse model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: We show that the local expression of the chemokine <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 was attenuated in CD38-deficient mice compared with <z:mp ids='MP_0002169'>wildtype</z:mp> mice after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, no significant induction of <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 expression was observed in peripheral blood after 6 hours </plain></SENT>
<SENT sid="6" pm="."><plain>Flow cytometry analysis revealed less infiltrating macrophages and lymphocytes in the ischemic hemisphere of CD38-deficient mice, whereas the amount of resident microglia was unaltered </plain></SENT>
<SENT sid="7" pm="."><plain>An up-regulation of CD38 expression was observed in macrophages and CD8(+) cells after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in <z:mp ids='MP_0002169'>wildtype</z:mp> mice, whereas CD38 expression was unchanged in microglia </plain></SENT>
<SENT sid="8" pm="."><plain>Finally, we demonstrate that CD38-deficiency decreases the cerebral ischemic injury and the persistent neurological deficit after three days of reperfusion in this murine temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) model </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION/SIGNIFICANCE: CD38 is differentially regulated following <z:hpo ids='HP_0001297'>stroke</z:hpo> and its deficiency attenuates the postischemic chemokine production, the immune cell infiltration and the cerebral injury after temporary <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore CD38 might prove a therapeutic target in <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
</text></document>